Erlotinib (Lortinib (150mg)) is a tyrosine kinase inhibitor, prescribed for metastatic non-small cell lung cancer, and pancreatic cancer.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Lortinib (150mg) - RPG Life Sciences Ltd.
Lortinib (150mg) Tablet
Generic : Erlotinib
₹
11159.8
150mg
10 Tablets
Substitute/Alternative Medication to Lortinib (150mg)
When is Lortinib (150mg) prescribed?
It is prescribed for -